Diethylcarbamazine: Difference between revisions
Ostermayer (talk | contribs) |
Ostermayer (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Administration== | ==Administration== | ||
*Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes | *Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes | ||
*Dosage Forms: | *Dosage Forms: tablets | ||
*Routes of Administration: | *Routes of Administration: oral | ||
*Common Trade Names: | *Common Trade Names: N/A | ||
==Adult Dosing== | ==Adult Dosing== | ||
[[Lymphatic filariasis]] | |||
*''including lymphatic filariasis caused by infection with Wuchereria bancrofti, Brugia malayi, or Brugia timori'' | |||
*Day 1: 50 mg PO PC | |||
*Day 2: 50 mg PO TID | |||
*Day 3: 100 mg PO TID | |||
*Day 4-14: 6 mg/kg/day PO divided TID | |||
[[Loa Loa]] | |||
*Day 1: 50 mg PO PC | |||
*Day 2: 50 mg PO TID | |||
*Day 3: 100 mg PO TID | |||
*Day 4-21: 9 mg/kg/day PO divided TID | |||
[[Mansonella streptocerca]] | |||
*6 mg/kg PO qDay x14 days | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
*Day 1: 1 mg/kg orally after meals | |||
*Day 2: 1 mg/kg orally three times daily | |||
*Day 3: 1-2 mg/kg orally three times daily | |||
*Day 4-14: 6 mg/kg/day orally divided three times daily | |||
==Special Populations== | ==Special Populations== | ||
| Line 40: | Line 56: | ||
==Pharmacology== | ==Pharmacology== | ||
*Half-life: | *Half-life: 8hrs | ||
*Metabolism: | *Metabolism: Partially metabolized to diethylcarbamazine N-oxide. | ||
*Excretion: | *Excretion: | ||
Revision as of 13:03, 3 April 2022
Overview
Diethylcarbamazine (DEC) used globally its anti-filaricidal activity[1]
Administration
- Mechanism of Action: interferes with cyclooxygenase and lipoxygenase pathways, reducing the production of thromboxane, prostacyclin, prostaglandin and leukotrienes
- Dosage Forms: tablets
- Routes of Administration: oral
- Common Trade Names: N/A
Adult Dosing
- including lymphatic filariasis caused by infection with Wuchereria bancrofti, Brugia malayi, or Brugia timori
- Day 1: 50 mg PO PC
- Day 2: 50 mg PO TID
- Day 3: 100 mg PO TID
- Day 4-14: 6 mg/kg/day PO divided TID
- Day 1: 50 mg PO PC
- Day 2: 50 mg PO TID
- Day 3: 100 mg PO TID
- Day 4-21: 9 mg/kg/day PO divided TID
- 6 mg/kg PO qDay x14 days
Pediatric Dosing
- Day 1: 1 mg/kg orally after meals
- Day 2: 1 mg/kg orally three times daily
- Day 3: 1-2 mg/kg orally three times daily
- Day 4-14: 6 mg/kg/day orally divided three times daily
Special Populations
Pregnancy Rating
Lactation risk
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life: 8hrs
- Metabolism: Partially metabolized to diethylcarbamazine N-oxide.
- Excretion:
Mechanism of Action
Comments
See Also
References
- ↑ Peixoto CA et al. Anti-inflammatory effects of diethylcarbamazine: A review. European Journal of Pharmacology 734 (2014) 35–41